Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- eslicarbazepine
- modafinil
Interactions between your drugs
modafinil eslicarbazepine
Applies to: modafinil, eslicarbazepine
MONITOR: Coadministration with inducers of CYP450 3A4 may decrease the plasma concentrations of modafinil (the racemate) and armodafinil (the R-enantiomer), which are both partially metabolized by the isoenzyme.
MANAGEMENT: Pharmacologic response to modafinil or armodafinil should be monitored more closely whenever a CYP450 3A4 inducer is added to or withdrawn from therapy. Dose adjustments may be required if an interaction is suspected.
References (6)
- Robertson P, Decory HH, Madan A, Parkinson A (2000) "In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil." Drug Metab Dispos, 28, p. 664-71
- (2007) "Product Information. Nuvigil (armodafinil)." Cephalon Inc
- (2024) "Product Information. Modafinil (modafinil)." Milpharm Ltd
- (2023) "Product Information. Modafinil (Apo) (modafinil)." Apotex Pty Ltd
- (2024) "Product Information. Apo-Modafinil (modafinil)." Apotex Incorporated
- (2024) "Product Information. Modafinil (modafinil)." Heritage Pharmaceuticals Inc
Drug and food interactions
modafinil food
Applies to: modafinil
Administration with food may delay the absorption of modafinil (the racemate) and armodafinil (the R-enantiomer) without significantly affecting their overall bioavailability. According to the product labeling, modafinil's absorption may be delayed by approximately one hour if taken with food. Similarly, the time to reach peak plasma concentration (Tmax) of armodafinil may be delayed by approximately 2 to 4 hours in the fed state.
References (2)
- (2001) "Product Information. Provigil (modafinil)." Cephalon, Inc
- (2007) "Product Information. Nuvigil (armodafinil)." Cephalon Inc
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Lyrica
Lyrica is used to control seizures, treat nerve pain and fibromyalgia. Learn about side effects ...
Lamictal
Lamictal is an anti-epileptic medication used treat seizures in adults and children over 2 years ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Depakote
Depakote is used to treat various types of seizure disorders. Learn about side effects ...
Ativan
Ativan is a benzodiazepine used to treat anxiety disorders or anxiety associated with depression ...
Keppra
Keppra is an anti-epileptic drug used to treat partial onset seizures in people with epilepsy ...
Klonopin
Klonopin (clonazepam) is used to control seizures in epilepsy and for the treatment of panic ...
Topamax
Topamax (topiramate) is used to prevent seizures in adults and children and to prevent migraine ...
Valium
Valium is used to treat anxiety disorders, alcohol withdrawal symptoms, or muscle spasms. Learn ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.